Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Ken has extensive experience in patenting a wide range of life sciences technologies including antibody therapeutics, small molecule modulators, diagnostics, immuno-oncotherapies, pharmaceutical formulations, gene editing, siRNA therapeutics, stem cell therapies, nanotechnologies, and machine learning and AI in Life Sciences technologies. He enjoys working closely with scientists to translate their discoveries to high value patent assets.
Ken works with a diverse set of clients, from research institutions to pre-funded startups to some of the world’s largest life sciences companies. He carefully tailors patent strategies to the specific business needs of each client while considering the ever-changing global patent case law landscape.
viewpoints
Copy Cats II: Nexus of Copying Required to Substantiate Non-Obviousness
February 17, 2021 | Blog | By Ken Jenkins
Year in Review: The Most Popular IP Posts of 2020
January 14, 2021 | Blog | By Christina Sperry
Federal Circuit Awards Attorney Fees to the Defendant Following Dismissal of Lawsuit by Plaintiff
January 7, 2020 | Blog | By Ken Jenkins
Copy Cats: Evidence of Copying a Specific Product NOT Required
November 12, 2019 | Blog | By Ken Jenkins
Prior Civil Action Bars IPR - A precedential decision
September 24, 2019 | Blog | By Ken Jenkins
Under New Guidance: Patent Eligibility of Computerized Diagnostics at the PTAB
May 15, 2019 | Blog | By Ken Jenkins
Prosecution Strategies for Avoiding Patent Eligibility Rejections for Diagnostics
November 19, 2018 | Blog | By Ken Jenkins
Inventorship
August 27, 2018 | Video | By Ken Jenkins
News & Press
Mintz Attorneys Named 2024 “Leaders of Influence in Life Sciences” by San Diego Business Journal
August 22, 2024
Mintz announced that Members Fred Hernandez and Ken Jenkins were named 2024 “Leaders of Influence in Life Sciences” by San Diego Business Journal (SDBJ) which recognizes individuals who are making significant contributions to the advancement of science, healthcare, and innovation in San Diego.
The Best Lawyers in America 2025 Recognizes 184 Mintz Attorneys across 56 Practice Areas
August 15, 2024
187 Mintz attorneys have been recognized by Best Lawyers® in the 2025 edition of The Best Lawyers in America©. Notably, three Mintz attorneys received 2025 “Lawyer of the Year” awards, and 64 firm attorneys were included in the 2025 edition of Best Lawyers: Ones to Watch.
Mintz IP Practice Recognized in 2024 IAM Patent 1000
June 18, 2024
Our Intellectual Property Practice earned national recognition in the 2024 edition of IAM Patent 1000 – The World’s Leading Patent Practitioners. The guide recognized Mintz with four firm-wide rankings and 14 individual attorney recommendations, including a gold ranking for Intellectual Property Chair Michael Renaud.
Mintz announced today that 42 of its practices and 83 of its attorneys earned recognition in the 2024 edition of Chambers USA, a guide to the country’s leading law firms. Of those included in the guide, 18 attorneys and seven practice areas were awarded Chambers’ highest ranking, Band 1. The firm obtained new listings in three practice areas and 10 of its lawyers were recognized for the first time.
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
Kenneth Jenkins Honored Among 2023 "Leaders Of Influence In Life Sciences" By San Diego Business Journal
July 24, 2023
San Diego, CA – Mintz is pleased to announce that Member Kenneth E. Jenkins, Ph.D. was named to San Diego Business Journal's 2023 “Leaders of Influence in the Life Sciences” special edition, which recognizes industry leaders in the life sciences and highlights their careers and accomplishments.
BOSTON, MA – In the 2023 edition of 'IP Stars,' published by Managing Intellectual Property (Managing IP), Mintz achieved recognition in two nationwide categories and received acknowledgment for the exceptional performance of nine of its attorneys.
BOSTON– Mintz’s award-winning Intellectual Property (IP) Practice again earned national recognition in the 2023 edition of IAM Patent 1000 – The World’s Leading Patent Practitioners. The guide recognized Mintz with three firm-wide rankings and 10 attorneys received a total of 11 individual recommendations.
BOSTON –Mintz announced today that 39 of its practices and 81 of its attorneys earned recognition in the 2023 edition of Chambers USA, a guide to the country’s leading law firms.
SAN DIEGO – Mintz is pleased to announce that four attorneys have been named San Diego Super Lawyers and three have been recognized as Rising Stars in the 2023 edition of the annual publication.
Pharma Refines Tricks To Tackle Section 112 But Left Frustrated
October 14, 2022
Mintz Member Kenneth Jenkins was quoted in an article published by Managing IP discussing developments in Section 112.
Why Counsel Should Watch Novartis SCOTUS Appeal
September 22, 2022
Best Lawyers® recognized 108 firm attorneys in the 2023 edition of The Best Lawyers in America©. Notably, two Mintz attorneys – Poonam Patidar and Scott M. Stanton – received 2023 “Lawyer of the Year” awards, and 28 firm attorneys were included in the inaugural edition of Best Lawyers: Ones to Watch.
How USPTO Pharma Reform Could Lower Counsel Spend
July 15, 2022
Mintz is pleased to share that two attorneys and the firm’s Patent practice have been shortlisted in the 2022 edition of Managing Intellectual Property’s (MIP) Americas Awards. The awards recognize the “remarkable achievements and developments” of firms, individuals and companies impacting the IP sector over the past year.
Mintz Practice Groups and Attorneys Garner Top Rankings in 2020 Edition of The Legal 500 United States
June 12, 2020
Twelve Mintz Attorneys Named 2017 Southern California Super Lawyers and Rising Stars
February 14, 2017
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Recognition & Awards
Recognized in Chambers USA: California – Intellectual Property: Patent Prosecution (2016 & 2017, 2021 – 2024)
San Diego Business Journal, Leader of Influence in Life Sciences (2023-2024)
IAM Patent 1000 "World's Leading Patent Practitioners" (2016 & 2017, 2019 – 2024)
Managing Intellectual Property: Patent star - California (2016 – 2024)
Best Lawyers in America: Patent Law (2017 – 2025)
San Diego Business Journal, Leaders in Law Award Finalist (2021)
Best Lawyers in America: "Lawyer of the Year" for Patent Law (2021, 2024)
San Diego Super Lawyers: Intellectual Property Law (2019 – 2023) / Southern California Super Lawyers Intellectual Property Law (2013-2017)
Daily Journal Top IP Lawyers (2020)
Recommended by The Legal 500 United States for Healthcare: Life Sciences (2020)
San Diego Business Journal: "Best of the Bar" (2014 - 2015)
San Diego Daily Transcript: “Transcript 10” attorney, Top Attorneys (2012)
San Diego Daily Transcript: “Best Young Attorney” (2008)
Young Investigator Award, Royal Society of Chemistry
Ken is an intellectual property attorney practicing in the patent prosecution and counseling space. He provides creative and carefully considered patent strategies designed to maximize patent portfolio value. In addition to patent procurement, Ken counsels lenders and investors in assessing the value of patent assets through due diligence reviews, including validity analyses, freedom-to-operate analyses, and in-licensed technology investigations.
Involvement
- Past president, San Diego Intellectual Property Law Association
- Member, BIOCOM Intellectual Property Committee